KORU Medical Systems (KORU Medical Systems) Change In Working Capital : $4.69 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is KORU Medical Systems Change In Working Capital?

KORU Medical Systems's change in working capital for the quarter that ended in Mar. 2024 was $0.66 Mil.

KORU Medical Systems's change in working capital for the fiscal year that ended in Dec. 2023 was $1.20 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

KORU Medical Systems Change In Working Capital Historical Data

The historical data trend for KORU Medical Systems's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

KORU Medical Systems Change In Working Capital Chart

KORU Medical Systems Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-1.55

-2.93

-1.11

1.40

1.20

KORU Medical Systems Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Working Capital	Get a 7-Day Free Trial															-2.82	1.93	-0.42	2.51	0.66

KORU Medical Systems Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.69 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

KORU Medical Systems Change In Working Capital Related Terms

Thank you for viewing the detailed overview of KORU Medical Systems's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

KORU Medical Systems (KORU Medical Systems) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » KORU Medical Systems Inc (NAS:KRMD) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

100 Corporate Drive, Mahwah, NJ, USA, 07430

Website

https://www.korumedical.com

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on home and specialty infusion solutions. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

Executives

Manko Joseph M. Jr.	10 percent owner	1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Kenneth E Miller	officer: Chief Commercial Officer	26 MOUNTAINVIEW RD, WARREN NJ 07059
Edward Wholihan	director	C/O ALLENA PHARMACEUTICALS, INC., ONE NEWTOWN EXECUTIVE PARK SUITE 202, NEWTON MA 02462
Linda M Tharby	officer: President and CEO	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Robert Cascella	director	C/O HOLOGIC, INC., BEDFORD MA 01730
Lafrence Andrew D.c.	officer: Chief Financial Officer	C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Thomas Edward Adams	officer: Interim CFO	524 WOODLAND AVENUE, BRIELLE NJ 08730
Brian Case	officer: Chief Technology Officer	424 CYPRUS CIR, LAKE VILLA IL 60046-8629
Shahriar Matin	director	96 TALAMINE COURT, COLORADO SPRINGS CO 80907
Donna French	director	25 SEARSVILLE COURT, HILLSBOROUGH CA 94010
Donald B Pettigrew	officer: Pres./Chief Commercial Officer	7871 ENGEN LOOP, PARK CITY UT 84098
Karen Fisher	officer: CFO	24 CARPENTER ROAD, CHESTER NY 10918
Daniel S Goldberger	director	24 CARPENTER ROAD, CHESTER NY 10918
R John Fletcher	director	C/O VYANT BIO, INC., 201 ROUTE 17 NORTH, 2ND FLOOR, RUTHERFORD NJ 07070
Horton Freedom, L.p.	10 percent owner	1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103